PharmIdea

PharmIdea Ltd. is the only sterile drug manufacturer in the Baltic States that meets the standards of Good Manufacturing Practice through applying innovative insulator technologies. PharmIdea's key business areas are development, manufacturing and sales of hospital, gynaecological and anti-cancer drugs. The company's main export directions are the EU, Middle East, Russia and other CIS countries; its future plans include registering products in South America, Southeast Asia, Canada and Mexico. PharmIdea's product portfolio includes four products, and another five products are currently being developed. The company's current manufacturing capacity is 200'000 sterile vials.